JUPITER NEUROSCIENCES, INC.
For the period ended Jun 30, 2025. Filed Aug 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 19, 2025
JUNS$2.200.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 30, | June 30, | June 30, | June 30, | |
| 2025 | 2024 | 2025 | 2024 | |
| Expenses: | ||||
| Research and development | $759,448 | $101,077 | $1,226,193 | $199,744 |
| General and administrative | 1,505,432 | 456,000 | 2,576,690 | 928,028 |
| Total operating expenses | 2,264,880 | 557,077 | 3,802,883 | 1,127,772 |
| Loss from operations | (2,264,880) | (557,077) | (3,802,883) | (1,127,772) |
| Other Income (Expenses): | ||||
| Interest income | 13,050 | 53 | 23,415 | 115 |
| Loss on change in fair value of derivative liability | - | (25,431) | - | (63,142) |
| Interest expense | (1,135) | (56,290) | (2,364) | (122,046) |
| Gain on extinguishment of debt | - | 951,868 | - | 951,868 |
| Other income | - | - | - | 40,000 |
| Total other income (expenses), net | 11,915 | 870,200 | 21,051 | 806,795 |
| Net (loss) income | $(2,252,965) | $313,123 | $(3,781,832) | $(320,977) |
| Net (loss) income per common share: | ||||
| Basic | $(0.07) | $0.01 | $(0.11) | $(0.01) |
| Diluted | $(0.07) | $0.01 | $(0.11) | $(0.01) |
| Weighted average number of common stock outstanding: | ||||
| Basic | 33,180,966 | 27,536,259 | 33,394,168 | 27,247,275 |
| Diluted | 33,180,966 | 30,592,311 | 33,394,168 | 27,247,275 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.